Becton Dickinson (BDX) EPS (Basic) Growth (3y) (2012 - 2026)
Analysis
Becton Dickinson (BDX) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 0.16% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 1.12% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 33.97% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -11.46% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 10.94% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 43.11% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 39.35% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 23.50% |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16% |
| Mar 31, 2026 | -39.58% |
| Dec 31, 2025 | -7.90% |
| Sep 30, 2025 | 22.61% |
| Jun 30, 2025 | 19.07% |
| Mar 31, 2025 | -10.81% |
| Dec 31, 2024 | -23.09% |
| Sep 30, 2024 | 18.17% |
| Jun 30, 2024 | -1.01% |
| Mar 31, 2024 | 24.92% |
| Dec 31, 2023 | -34.04% |
| Sep 30, 2023 | 0.08% |
| Jun 30, 2023 | 11.75% |
| Mar 31, 2023 | 42.44% |
| Dec 31, 2022 | 24.59% |
| Sep 30, 2022 | 26.16% |
| Jun 30, 2022 | -8.15% |
| Mar 31, 2022 | 191.05% |
| Dec 31, 2021 | 3.27% |
| Sep 30, 2021 | 48.11% |